000 | 01071 a2200313 4500 | ||
---|---|---|---|
005 | 20250513145321.0 | ||
264 | 0 | _c19981008 | |
008 | 199810s 0 0 eng d | ||
022 | _a1095-0680 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMiller, A R | |
245 | 0 | 0 |
_aReversible ischemic neurologic deficit after ECT. _h[electronic resource] |
260 |
_bThe journal of ECT _cMar 1998 |
||
300 |
_a42-8 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Clinical Trial; Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 |
_aAncrod _xadministration & dosage |
650 | 0 | 4 |
_aBrain Ischemia _xdiagnosis |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 |
_aDepressive Disorder, Major _xdiagnosis |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 |
_aElectroconvulsive Therapy _xadverse effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFibrinolytic Agents _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeurologic Examination |
700 | 1 | _aIsenberg, K E | |
773 | 0 |
_tThe journal of ECT _gvol. 14 _gno. 1 _gp. 42-8 |
|
999 |
_c9627134 _d9627134 |